YMAGUS
LIVE

Serial Number

79223669

Owner

Novartis AG

Filing Date

Nov 29, 2017

Add to watchlist:

No watchlists yet
View on USPTO

YMAGUS Trademark

Serial Number: 79223669 • Registration: 5461556

YMAGUS is a trademark filed by Novartis AG on November 29, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

November 29, 2017

Registration Date

May 8, 2018

Published for Opposition

February 20, 2018

Cancellation Date

November 22, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

GENERIC MADRID TRANSACTION SENT TO IB
Apr 28, 2026 XXSS
GENERIC MADRID TRANSACTION CREATED
Apr 28, 2026 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jul 22, 2025 INTR
CANCELLED SECTION 71
Nov 22, 2024 C71T
NOTIFICATION PROCESSED BY IB
Aug 17, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jun 15, 2018 FICS
FINAL DISPOSITION PROCESSED
Jun 15, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jun 7, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
May 8, 2018 R.PR
PUBLISHED FOR OPPOSITION
Feb 20, 2018 PUBO
NOTICE OF PUBLICATION
Jan 31, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2018 CNSA
ASSIGNED TO EXAMINER
Jan 3, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 30, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 26, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 22, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 21, 2017 SDRC